EI Ventures

EI Ventures develops low-dose botanical psychedelics and medicinal mushroom nutraceuticals, creating an integrated wellness platform designed for mental health, anxiety, and cognitive wellness. The company’s approach involves proprietary formulations, leveraging extensive intellectual property and strategic partnerships to advance its product pipeline. They build a holistic care model combining these novel therapies with tele-psychiatry to enhance accessibility and efficacy.

Founded in 2019 by David Nikzad and Jason Hobson, EI Ventures emerged from an insight into the unmet demand for effective mental health solutions and the potential of psychedelic medicine. David Nikzad, a seasoned entrepreneur with a history of founding successful ventures like Orthogonal Thinker, identified the opportunity to pioneer a new standard in mental wellness, drawing on his diverse experience in technology and wellness.

The company primarily serves individuals seeking innovative and natural treatments for various mental and cognitive challenges. EI Ventures’ long-term vision is to lead the psychedelic therapy industry by making plant-powered remedies accessible, thereby fundamentally transforming mental healthcare. They aim to establish a new paradigm in wellness through scientifically-backed botanical solutions.